| Bioactivity | Antitumor agent-135 (Compound 13) is a potent antitumor agent. Antitumor agent-135 induces cell apoptosis, with IC50s of 3.79 , 10.55, 1.14, and 4.14 μM for NSCLC cell lines (A549, H460, PC-9, and PC-9/GR)[1]. |
| Name | Antitumor agent-135 |
| Formula | C68H77N13O16 |
| Molar Mass | 1332.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wei B, et al. Design, synthesis and bioactivity evaluation of the combination of evodiamine and erlotinib linked by indolequinone. Bioorg Med Chem Lett. 2024 Jan 18;99:129619. |
Antitumor agent-135
CAS: F: C68H77N13O16 W: 1332.42
Antitumor agent-135 (Compound 13) is a potent antitumor agent. Antitumor agent-135 induces cell apoptosis, with IC50s of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.